STXI ETF Analysis

이 페이지는 영어 원문에서 AI로 기계 번역되었습니다. 영어 버전이 기준입니다. 영어 버전 읽기

정보 제공만을 목적으로 합니다. 재정적 조언이 아닙니다.

빠른 답변

In the stored portfolio snapshot dated Mar 15, 2026, the largest listed holding is ASML Holding NV (ASML.AS) at 2.94%.

STXI ETF — Price, Holdings & Analysis

ETF 개요

STXI aims to replicate the performance of an index comprised of a small selection of global stocks. The ETF achieves this by investing in the constituent companies of the underlying index, weighting them according to their index representation. STXI offers a concentrated approach to global equities, potentially leading to higher volatility compared to more diversified ETFs. The fund's top holdings include ASML Holding NV (2.94%), Novartis AG Registered Shares (1.77%), and Roche Holding AG (1.77%). Other significant allocations include HSBC Holdings PLC (1.71%) and AstraZeneca PLC (1.67%). This concentrated portfolio may appeal to investors seeking targeted exposure to specific global companies rather than broad market diversification. STXI's strategy is suited for investors with a higher risk tolerance seeking concentrated exposure.

위험 지표

STXI's presents a significant concentration risk. A downturn in any of its top holdings, such as ASML Holding NV, Novartis AG, or Roche Holding AG, could disproportionately impact the ETF's performance. The ETF's three-year beta of 0.00 suggests it has historically exhibited very low volatility relative to the market. However, this may not hold true in all market conditions, especially given the concentrated nature of its holdings. Investors should carefully consider their risk tolerance and investment objectives before investing in STXI, acknowledging the potential for amplified volatility due to its concentrated nature. Past performance does not guarantee future results.

베타: 0.00

STXI은(는) 무엇을 보유하고 있나요?

보유 종목	비중
ASML Holding NV (ASML.AS)	2.94%
Novartis AG Registered Shares (NOVN.SW)	1.77%
Roche Holding AG (ROG.SW)	1.77%
HSBC Holdings PLC (HSBA.L)	1.71%
AstraZeneca PLC (AZN.L)	1.67%
Nestle SA (NESN.SW)	1.49%
Toyota Motor Corp (7203.T)	1.33%
Shell PLC (SHEL.L)	1.26%
Siemens AG (SIE.DE)	1.20%
Royal Bank of Canada (RY)	1.18%

보유 종목 및 비중: 2026년 3월 15일 기준. 이 펀드 데이터는 45일 이상 지났습니다. 최신 보유 종목은 발행사에서 확인하세요.

배당수익률

0.00%

질문 및 답변

What is STXI and what does it track?

STXI is an exchange-traded fund (ETF) designed to track the performance of a specific index composed of a small selection of global stocks.

The ETF provides investors with a way to gain exposure to these companies through a single investment vehicle. As of 2026-03-15, with top allocations including ASML Holding NV, Novartis AG, and Roche Holding AG.

What are the top holdings in STXI?

As of 2026-03-15, the top five holdings in STXI are: 1) ASML Holding NV (ASML.AS) at 2.94%, 2) Novartis AG Registered Shares (NOVN.SW) at 1.77%, 3) Roche Holding AG (ROG.SW) at 1.77%, 4) HSBC Holdings PLC (HSBA.L) at 1.71%, and…

5) AstraZeneca PLC (AZN.L) at 1.67%.

Is STXI a good long-term investment?

Whether STXI is a suitable long-term investment depends on an investor's individual circumstances, risk tolerance, and investment objectives. The ETF's may lead to higher volatility compared to more diversified options.

As of 2026-03-15, STXI has a dividend yield of 0.00% and a three-year beta of 0.00. Investors should carefully consider these factors and conduct thorough research before making any investment decisions. Past performance does not guarantee future results.

How does STXI compare to similar ETFs?

However, STXI's defining characteristic is its highly. Many similar ETFs tracking global equities will hold a much larger number of companies, providing greater diversification.

Investors should compare STXI's expense ratio (not available in provided data), AUM, and investment strategy to those of other global equity ETFs to determine which fund best aligns with their needs. The level of concentration is a key differentiator.

Does STXI pay dividends?

As of 2026-03-15, STXI exhibits a dividend yield of 0.00%. This indicates that the ETF is not currently distributing any dividend income to its shareholders. Investors seeking dividend income may want to consider alternative ETFs with a higher dividend yield.

However, dividend yield is only one factor to consider when evaluating an ETF's overall suitability.

면책 조항: 이 콘텐츠는 정보 제공만을 목적으로 하며 투자 조언을 구성하지 않습니다. 항상 자체 조사를 수행하고 재정 고문과 상담하십시오.

데이터는 정보 제공만을 목적으로 제공됩니다.

이 페이지는 기계가 작성했으며, 페이지별 사람 검수는 거치지 않았습니다. 편집 관리는 체계 차원에서 이루어집니다: 규칙과 출처를 점검하며, 개별 페이지는 점검하지 않습니다.